Table 2.
Summary of lead cis-eQTL per subpopulation
| Subpopulation | No. of lead cis-eQTL | No. of eGenes | No. of eSNPs |
|---|---|---|---|
| RPC1 | 539 | 539 | 537 |
| RPC2 | 233 | 233 | 232 |
| RPC3 | 180 | 180 | 180 |
| RPC4 | 377 | 377 | 368 |
| RPC5 | 245 | 245 | 245 |
| RPC6 | 115 | 115 | 115 |
| RPC7 | 108 | 108 | 103 |
| RPC8 | 268 | 268 | 263 |
| RPC9 | 122 | 122 | 113 |
| RPC10 | 261 | 261 | 257 |
| RPC11 | 205 | 205 | 201 |
| RPC12 | 227 | 227 | 226 |
| RPC13 | 147 | 147 | 147 |
| RPC14 | 38 | 38 | 38 |
| RPC15 | 208 | 208 | 206 |
| RGC1 | 382 | 382 | 381 |
| RGC2 | 124 | 124 | 123 |
| RGC3 | 131 | 131 | 130 |
| Interneurons | 245 | 245 | 239 |
| Photoreceptors | 184 | 184 | 183 |
| RPE | 97 | 97 | 94 |
| Lens | 7 | 7 | 7 |
cis-eQTL from disease model were filtered by the following thresholds: FDR < 0.05; eGene expression > 30%. Lead cis-eQTL were selected based on SNP-gene interaction with lowest FDR value.